Androgen receptor outwits prostate cancer drugs

This publication has 12 references indexed in Scilit:

• Molecular determinants of resistance to antiandrogen therapy
  Nature Medicine, 2003
• Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer
  British Journal of Cancer, 2003
• Is the Achilles’ Heel for Prostate Cancer Therapy a Gain of Function in Androgen Receptor Signaling?
  Journal of Clinical Endocrinology & Metabolism, 2003
• Reducing the Agonist Activity of Antiandrogens by a Dominant-negative Androgen Receptor Coregulator ARA70 in Prostate Cancer Cells
  Journal of Biological Chemistry, 2003
• The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
  The American Journal of Pathology, 2003
• Heparin-Binding Epidermal Growth Factor-Like Growth Factor Stimulates Androgen-Independent Prostate Tumor Growth and Antagonizes Androgen Receptor Function
  Endocrinology, 2002
• Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor
  Cancer Gene Therapy, 2002
• Antagonist/Agonist Balance of the Nonsteroidal Antiandrogen Bicalutamide (Casodex) in a New Prostate Cancer Model
  Urologia Internationalis, 2000
• Prostate Specific Antigen Decreases After Withdrawal of Antiandrogen Therapy with Bicalutamide or Flutamide in Patients Receiving Combined Androgen Blockade
  Journal of Urology, 1997
• Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.
  Journal of Clinical Oncology, 1993